JP2022502476A5 - - Google Patents
Info
- Publication number
- JP2022502476A5 JP2022502476A5 JP2021521024A JP2021521024A JP2022502476A5 JP 2022502476 A5 JP2022502476 A5 JP 2022502476A5 JP 2021521024 A JP2021521024 A JP 2021521024A JP 2021521024 A JP2021521024 A JP 2021521024A JP 2022502476 A5 JP2022502476 A5 JP 2022502476A5
- Authority
- JP
- Japan
- Prior art keywords
- iii
- pharmaceutically acceptable
- ring
- acceptable salt
- viii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862746277P | 2018-10-16 | 2018-10-16 | |
| US62/746,277 | 2018-10-16 | ||
| PCT/US2019/056455 WO2020081636A1 (en) | 2018-10-16 | 2019-10-16 | Indole ahr inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022502476A JP2022502476A (ja) | 2022-01-11 |
| JP2022502476A5 true JP2022502476A5 (enExample) | 2022-10-25 |
Family
ID=70284697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521024A Pending JP2022502476A (ja) | 2018-10-16 | 2019-10-16 | インドールａｈｒ阻害剤およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220144839A1 (enExample) |
| EP (1) | EP3867253A4 (enExample) |
| JP (1) | JP2022502476A (enExample) |
| KR (1) | KR20210110566A (enExample) |
| CN (1) | CN113272305A (enExample) |
| AU (1) | AU2019360204A1 (enExample) |
| BR (1) | BR112021007017A2 (enExample) |
| CA (1) | CA3115711A1 (enExample) |
| EA (1) | EA202190726A1 (enExample) |
| IL (1) | IL282252A (enExample) |
| MX (1) | MX2021004245A (enExample) |
| SG (1) | SG11202103796TA (enExample) |
| WO (1) | WO2020081636A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019012431A (es) | 2017-04-21 | 2020-08-03 | Ikena Oncology Inc | Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos. |
| AU2020394424A1 (en) | 2019-11-26 | 2022-06-16 | Ikena Oncology, Inc. | Polymorphic carbazole derivatives and uses thereof |
| BR112022013673A2 (pt) | 2020-01-10 | 2022-09-13 | Ikena Oncology Inc | Inibidores de ahr e seus usos |
| WO2021236717A1 (en) | 2020-05-20 | 2021-11-25 | Senda Biosciences, Inc. | Fused imidazole derivatives as ahr antagonists |
| CA3182093A1 (en) * | 2020-06-10 | 2021-12-16 | Florence Wagner | Tricyclic psychoplastogens and uses thereof |
| CN114369097B (zh) * | 2020-10-15 | 2023-07-14 | 山东轩竹医药科技有限公司 | 杂芳环类AhR抑制剂 |
| CA3196535A1 (en) * | 2020-10-28 | 2022-05-05 | Alfredo C. Castro | Combination of an ahr inhibitor with a pdx inhibitor or doxorubicine |
| US12540141B2 (en) | 2020-11-23 | 2026-02-03 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| WO2022109360A1 (en) | 2020-11-23 | 2022-05-27 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| CN114456178B (zh) * | 2021-01-13 | 2023-06-02 | 北京华森英诺生物科技有限公司 | 四氢嘧啶[1,2-b]吲唑-4-胺类衍生物作为AhR抑制剂的用途及制备方法 |
| CN114805361B (zh) * | 2021-01-17 | 2024-02-20 | 上海凌达生物医药有限公司 | 一类氨基取代的芳香杂环并吡唑类化合物、制备方法和用途 |
| US11970502B2 (en) | 2021-05-04 | 2024-04-30 | Enanta Pharmaceuticals, Inc. | Macrocyclic antiviral agents |
| WO2023086352A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| US11858945B2 (en) | 2021-11-12 | 2024-01-02 | Enanta Pharmaceuticals, Inc. | Alkyne-containing antiviral agents |
| WO2023086400A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| US11993600B2 (en) | 2021-12-08 | 2024-05-28 | Enanta Pharmaceuticals, Inc. | Saturated spirocyclics as antiviral agents |
| US12006291B2 (en) | 2022-01-11 | 2024-06-11 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid |
| US12145942B2 (en) | 2022-04-05 | 2024-11-19 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| EP4504341A1 (en) | 2022-04-08 | 2025-02-12 | Shy Therapeutics LLC | Compounds that interact with ras superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| CN117624168A (zh) * | 2022-08-19 | 2024-03-01 | 德明药泰生物技术（深圳）有限公司 | 稠环杂环类化合物及其制备方法和应用 |
| EP4617262A1 (en) | 2022-11-07 | 2025-09-17 | Kyoto University | Nitrogen-containing heterocyclic compound |
| KR20240169284A (ko) | 2023-05-24 | 2024-12-03 | 경희대학교 산학협력단 | AhR-매개 질환의 예방, 개선 또는 치료용 약학적 조성물 |
| WO2025114771A1 (en) | 2023-11-29 | 2025-06-05 | Latvian Institute Of Organic Synthesis | A new class of aryl hydrocarbon receptor antagonists and their optimisation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5721356A (en) * | 1989-09-15 | 1998-02-24 | Gensia, Inc. | Orally active adenosine kinase inhibitors |
| JP4895806B2 (ja) * | 2003-04-09 | 2012-03-14 | エクセリクシス， インク． | Ｔｉｅ−２モジュレータと使用方法 |
| TW200536536A (en) * | 2004-02-25 | 2005-11-16 | Schering Corp | Pyrazolotriazines as kinase inhibitors |
| PE20100362A1 (es) * | 2008-10-30 | 2010-05-27 | Irm Llc | Derivados de purina que expanden las celulas madre hematopoyeticas |
| CN108290855A (zh) * | 2015-07-01 | 2018-07-17 | 西北大学 | 被取代的喹唑啉化合物及其调节葡糖脑苷脂酶活性的用途 |
| US20180072741A1 (en) * | 2016-09-09 | 2018-03-15 | Incyte Corporation | Pyrazolopyrimidine compounds and uses thereof |
| MX2019012431A (es) * | 2017-04-21 | 2020-08-03 | Ikena Oncology Inc | Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos. |
-
2019
- 2019-10-16 KR KR1020217014753A patent/KR20210110566A/ko not_active Withdrawn
- 2019-10-16 WO PCT/US2019/056455 patent/WO2020081636A1/en not_active Ceased
- 2019-10-16 SG SG11202103796TA patent/SG11202103796TA/en unknown
- 2019-10-16 EP EP19873025.1A patent/EP3867253A4/en not_active Withdrawn
- 2019-10-16 CN CN201980076086.7A patent/CN113272305A/zh active Pending
- 2019-10-16 US US17/281,395 patent/US20220144839A1/en not_active Abandoned
- 2019-10-16 CA CA3115711A patent/CA3115711A1/en active Pending
- 2019-10-16 AU AU2019360204A patent/AU2019360204A1/en not_active Abandoned
- 2019-10-16 BR BR112021007017-6A patent/BR112021007017A2/pt not_active IP Right Cessation
- 2019-10-16 JP JP2021521024A patent/JP2022502476A/ja active Pending
- 2019-10-16 EA EA202190726A patent/EA202190726A1/ru unknown
- 2019-10-16 MX MX2021004245A patent/MX2021004245A/es unknown
-
2021
- 2021-04-12 IL IL282252A patent/IL282252A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020517734A5 (enExample) | ||
| JP2020531461A5 (enExample) | ||
| JP2022516401A5 (enExample) | ||
| Haiges et al. | 5-(Fluorodinitromethyl)-2 H-tetrazole and its tetrazolates–Preparation and Characterization of New High Energy Compounds | |
| JP2020532592A5 (enExample) | ||
| Siegl | Metal‐chelating 1, 3‐bis (2′‐pyridylimino) isoindolines | |
| Fershtat et al. | Design of hetarylthiofuroxans by nucleophilic substitution of NO 2 group in nitrofuroxans | |
| NO161179B (no) | Lagringsmateriale for lagring av termisk energi og fremgangsmaate til fremstilling av materialet. | |
| US20220144839A1 (en) | Indole ahr inhibitors and uses thereof | |
| WO2024137665A3 (en) | Rubber compositions comprising antidegradants | |
| JPS6372602A (ja) | イミダゾリノン除草剤類の水性除草剤組成物類 | |
| TH1901006700A (th) | สารยับยั้ง ahr ชนิดอินโดลและการใช้สารดังกล่าว | |
| DK171439B1 (da) | Fremgangsmåde til fremstilling af en 2-(5,5-disubstitueret 4-oxo(eller -thiono)-2-imidazolin-2-yl)-nicotinsyre, -3-quinolincarboxylsyre eller -benzoesyre eller et derivat deraf | |
| JP5980808B2 (ja) | トリアジニル−置換オキシインドール類を製造する方法 | |
| ES2318272T3 (es) | Metodos para hacer 6-((4,5-dihidro-1h-imidazol-2-il)amino-)-7-metil-1h-benzimidazol-4-carbonitrilo y su forma de sal preferida. | |
| US3813439A (en) | Process for preparation of triamino-guanidine and its salts | |
| Frankel et al. | Derivatives of Dicyanamide1 | |
| WO2005003104A2 (en) | Crystalline forms of lamotrigine monohydrate and anhydrous lamotrigine and a process for their preparation | |
| Jalový et al. | Contribution to the Synthesis of 4, 10-Dinitro-2, 6, 8, 12-tetraoxa-4, 10-diazatetracyclo [5.5. 0.05, 903, 11] dodecane (TEX) | |
| CS269077B1 (cs) | Způsob přípravy 5-azacytosinů | |
| AU8639891A (en) | Method for making certain pyrano(3',4':6,7)indolizino(1,2-b)quinolinones | |
| US4252944A (en) | 4-Amino-6-(2-carboxyphenyl)-3-mercapto-1,2,4-triazin-5(4H)-one | |
| Dyablo et al. | Synthesis of 6-methoxy-N 2, N 2, N 4, N 4, N 5, N 5-hexamethylquinoline-2, 4, 5-triamine–a new representative of quinoline proton sponges | |
| KAUR | DERIVATIZATION OF TRIAZINES AND THEIR EVALUATION AS ANTIFUNGAL AGENTS | |
| Chapyshev | Recent progress in the chemistry of polyazidoazines |